RO7496998
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RO7496998, covering 2023-07-28 to 2024-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19 [Phase 3]